Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations.
Publication/Presentation Date
4-1-2016
Abstract
Inflammation is increasingly being recognized as contributing to the underlying pathophysiology of cerebral aneurysms and brain arteriovenous malformation. Ferumoxytol is being increasingly used for both its prolonged intravascular imaging characteristics and its utility as an inflammatory marker when imaged in a delayed fashion. We aim to present a review article on the use of ferumoxytol to assess cerebral aneurysms and arteriovenous malformation. This could potentially help assist the physician in his judgment for intervening, as aneurysms that look macroscopically the same may behave differently.
Volume
25
Issue
2
First Page
57
Last Page
61
ISSN
1536-1004
Published In/Presented At
Zanaty, M., Chalouhi, N., Starke, R. M., Jabbour, P., & Hasan, D. (2016). Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations. Topics in magnetic resonance imaging : TMRI, 25(2), 57–61. https://doi.org/10.1097/RMR.0000000000000086
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27049242
Department(s)
Administration and Leadership
Document Type
Article